The process of apoptosis (programmed cell death) has become the subject of intensive and extensive research over the past few years. Various approaches are being used to identify and study genes which function as positive mediators of apoptosis. Here, we address a novel approach of gene cloning aimed at isolating intracellular death promoting genes by utilizing a functional screen. This method, called TKO, was based on transfection of cells with an anti-sense cDNA library, followed by the selection of transfectants which survived in the continuous presence of a killing cytokine ± interferon-g. It led to the identi®cation of ®ve novel apoptotic genes and to the ®nding that a known protease ± cathepsin D, is actively recruited to the death process. The ®ve novel apoptotic genes (named DAP genes for: Death Associated Proteins) code for proteins which display a diverse spectrum of biochemical activities. The list comprises a novel type of calcium/calmodulin-regulated kinase which carries ankyrin repeats and a death domain (DAPkinase), a nucleotide-binding protein (DAP-3), a small proline-rich cytoplasmic protein (DAP-1), and a novel homolog of the eIF4G translation initiation factor (DAP-5). Extensive studies proved that these genes are critical for mediating cell death initiated by interferon-g, and in some of the tested cases also cell death induced by Fas/APO-1, TNF-a, and a detachment from extracellular matrix. Moreover, one of these genes, DAP-kinase, was recently found to display strong tumor suppressive activities, coupling the control of apoptosis to metastasis.
The process of apoptosis (programmed cell death) has become the subject of intensive and extensive research over the past few years. Various approaches are being used to identify and study genes which function as positive mediators of apoptosis. Here, we address a novel approach of gene cloning aimed at isolating intracellular death promoting genes by utilizing a functional screen. This method, called TKO, was based on transfection of cells with an anti-sense cDNA library, followed by the selection of transfectants which survived in the continuous presence of a killing cytokine ± interferon-g. It led to the identi®cation of ®ve novel apoptotic genes and to the ®nding that a known protease ± cathepsin D, is actively recruited to the death process. The ®ve novel apoptotic genes (named DAP genes for: Death Associated Proteins) code for proteins which display a diverse spectrum of biochemical activities. The list comprises a novel type of calcium/calmodulin-regulated kinase which carries ankyrin repeats and a death domain (DAPkinase), a nucleotide-binding protein (DAP-3), a small proline-rich cytoplasmic protein (DAP-1), and a novel homolog of the eIF4G translation initiation factor (DAP-5). Extensive studies proved that these genes are critical for mediating cell death initiated by interferon-g, and in some of the tested cases also cell death induced by Fas/APO-1, TNF-a, and a detachment from extracellular matrix. Moreover, one of these genes, DAP-kinase, was recently found to display strong tumor suppressive activities, coupling the control of apoptosis to metastasis.
The advantage of functional approaches of gene cloning is that they select the relevant rate limiting genes along the death pathways in a complete unbiased manner. As a consequence, novel targets and unpredicted mechanisms emerged. A few examples illustrating this important point will be discussed. One relates to the calcium/calmodulin-dependent DAP-kinase, which is localized to the actin micro®laments. It was found that the correct localization of DAP-kinase to the micro®la-ment network was critical for the execution of the apoptotic process, and more speci®cally for the disruption of the stress ®bers ± a typical hallmark of apoptosis. Another important breakthrough step in our understanding of apoptotic processes relates to the identi®ca-tion and analysis of the DAP-5 gene. The structure/ function features of this novel translation regulator resemble the proteolytically cleaved eIF4G which appears in cells upon infection with some RNA viruses and which directs cap-independent translation. Thus, the rescue of DAP-5 highlighted the importance of regulation of protein translation in certain apoptotic systems. Finally, the isolation of cathespin D by our method
Introduction
Programmed cell death is a genetically controlled response of cells to commit suicide. The process, which displays distinctive morphological features, is highly conserved through evolution, and takes place in all nucleated animal cells. It is tightly controlled by environmental stimuli including extracellular diusible factors, or membrane-bound molecules that mediate cell ± cell or cell ± matrix interactions, and by nonphysiological insults such as genotoxic agents. This type of regulation allows the elimination of cells that were either produced in excess during development, have completed their role, are potentially deleterious to the organism, or have become seriously damaged. Programmed cell death is therefore a critical process during embryonic development, tissue remodeling, development of the immune system, and the control of tissue homeostasis (for reviews see Wyllie et al., 1980; Ra, 1992; Schwartz and Osborne, 1993) . Several pathologies associated with the disruption of this fundamental process, have been characterized. While a decrease in the apoptotic rate is linked in some cases to abnormal expansion in cell number (e.g., in cancer or autoimmune diseases), an abnormal increase in the apoptotic rate is associated with some cell loss disorders (e.g. neurodegenerative diseases) (Thompson, 1995) . The link to cancer takes place at the dierent stages of tumor development, one of which includes the loss of an early apoptotic checkpoint that safeguards cells against hyperproliferative oncogenic signals (Evan and Littlewood, 1998) .
The spectrum of morphological hallmarks that has been attributed to the process is very wide, and includes speci®c nuclear alterations (e.g., chromatin condensation followed by its segmentation, internucleosomal DNA fragmentation), cytoplasmic condensation and/or vacuolization, disruption of cytoskeletal elements, cell surface blebbing, and in some cases, generation of apoptotic bodies that are rapidly phagocytosed by neighboring cells. The understanding of molecular mechanisms underlying these dierent cellular alterations has become, in the past few years, a major research goal in the ®eld. The main challenge, in this respect, was to identify the genes that are components of the intracellular pathways which enable cells to receive, process and execute apoptotic signals from their environment. There has been an impressive progress in the past few years in understanding the intracellular molecule mechanisms of programmed cell death, emerging from studying both lower invertebrates and mammalian systems (see for examples Hengarthner and Horovitz, 1994; Steller, 1995; Thornberry and Lazebnik, 1998; Adams and Corry, 1998; Green and Reed, 1998 ). Yet, it is clear that many of the components functioning along the apoptotic pathways have not been discovered, which means that novel approaches and dierent insights should be introduced into this ®eld. This paper will focus on one of these recently developed approaches which is based on a powerful genetic screen applied in mammalian cells. The novel molecular information obtained so far by this approach will be detailed, and future prospects will be discussed.
Hunting genes according to their function: the technical knock out (TKO) approach
The TKO strategy was designed with the intention of establishing a technology that will directly target functionally relevant genes involved in cell death, in a manner similar to the genetic screens used in Drosophila melanogaster or in C elegans. Instead of mutating the DNA, we directed our eorts at randomly inactivating gene expression by targeting the RNA, thereby bypassing the limitations of mammalian cells that lack the powerful genetic tools available in lower invertebrates. The targeting was performed in an unbiased manner by transfections with anti-sense cDNA expression libraries and producing a wide spectrum of complementary RNAs (Deiss and Kimchi, 1991) . The assumption was that the speci®c antisense RNAmediated inactivation of a rate limiting death-promoting gene would confer some growth advantage to cells that are continuously exposed to a killing agent. This advantage could then be used as a powerful forward selection to rescue the relevant cDNA. In other words, the genes of interest are selected and cloned by virtue of a de®ned phenotypic change ± reduced susceptibility to death-inducing signals.
Interferon-g (IFN-g) was chosen as the preferred external agent which induces strong apoptotic responses in some target cells. In HeLa cells we found that this cytokine imposed a biphasic pattern of responses, i.e., a reversible proliferation arrest followed by programmed cell death . This provided a unique system to study, within a single genetic constellation, the points where the cell cycle inhibitory and apoptotic mechanisms diverge. The cDNA library itself was designed to yield high levels of antisense RNAs by virtue of the fact that: the library was cloned into an EBV-based episomal vector which allows high copy number of episomes per cell; and the expression vector contained an IFN response element to further elevate the expression of antisense RNAs during the selection in the presence of IFN-g (Deiss and Kimchi, 1991) . The vector also included a resistance gene to the drug hygromycin B, thus eliminating the background of untransfected cells. In addition, the episomal nature of the vector allowed easier rescue of antisense cDNAs from surviving clones.
The rescue of cell-death protective cDNA fragments As depicted in Figure 1 , the cDNA library (prepared from a mixture of untreated and IFN-g-treated HeLa Figure 1 Outline of the TKO strategy, applied in IFN-g-treated HeLa cells. The cDNA fragments that were scored as positives in a second round of transfection were subjected to further analysis, and are described in Table 1 . (For more details see Deiss and Kimchi, 1991; Deiss et al., 1995) cells) was introduced by transfection into HeLa cells. The entire cell population was then exposed for 3 ± 4 weeks to IFN-g and the hygromycin B selection drug. Finally, surviving cells were isolated, and episomal vectors rescued from these cells were individually tested in a second round of transfection/selection in HeLa cells, in order to con®rm the phenotype. The plasmids that were scored as positive clones in the second round were further analysed. Southern and Northern blot analysis classi®ed the functional antisense fragments carried by these vectors into seven non-overlapping groups of cDNAs, corresponding to seven dierent genes (Table 1 ). Sequence analysis indicated that ®ve groups corresponded to novel genes. We named them: Death Associated Protein (DAP) genes, DAP-1 to DAP-5 (Table 1 ; DAP-2 is also called DAP-kinase). Two groups represented known genes: the thioredoxin gene, whose product is involved in redox regulation of intramolecular disul®de bonds in proteins; and cathepsin-D, which is an aspartyl lysosomal protease. Basic information concerning the size of mRNAs encoded by the selected genes, as well as their chromosomal assignment, is shown in Table 1 .
From that point, we focused on the molecular and functional characterization of the novel DAP genes. Towards this aim, the full-length sense cDNAs were isolated, speci®c antibodies were raised against the recombinant proteins, and the expression, function, and biochemical properties of the proteins were studied. In addition, the possible link of one of these genes to cancer has been addressed, as well as the unpredicted ®nding that an aspartyl protease is essential for apoptosis.
DAP-kinase studies
The study of this gene provides an interesting paradigm, illustrating how from the initial selection of death-protective anti-sense cDNA fragment, we proceeded towards the structure/function analysis of the protein, and then to the notion that a central`death gene', with a potential tumor suppressor activity, has been isolated.
Once the full-length cDNA clone of DAP-2 was isolated, the deduced amino acid structure predicted that a novel calmodulin-dependent serine/threonine type kinase (160 kDa) had been isolated (Figure 2 ). Its kinase domain has a classical 12 subdomain composition, typical of serine/threonine kinases, followed by a region that shares high homology with the calmodulin regulatory domains of other kinases. Adjacent to the latter, we found eight ankyrin repeats followed by two P-loop motifs . This provided the ®rst documented example of a serine/ threonine kinase carrying ankyrin repeats, a motif involved in the formation of stable protein ± protein complexes, which may mediate the interaction of DAPkinase with its downstream or upstream eectors. Moreover, a typical death-domain module was identi®ed at the 3' end of the protein, followed by a stretch of amino acids that is rich in serines (Feinstein et al., 1995a) . The death domain of DAP-kinase contains all the boxes of homology and the conserved amino acids characteristic of the analogous domains in other death domain-containing proteins (Feinstein et al., 1995a) . Many of these other proteins have a direct involvement in programmed cell death, including the p55 TNF receptor, the Fas/APO-1 receptor, DR3-5, FADD/MORT-1, RIP, TRADD and RAIDD (Ashkenazi and Dixit, 1998) . Being a motif composed of several a-helical regions, the death domain of DAPkinase may prompt association with other protein partners critical for the function of this novel type of kinase. The serine rich C-terminal tail of DAP-kinase could negatively regulate a putative function of the death domain, as previously shown for the corresponding region in the Fas/APO-1 receptor (Feinstein et al., 1995a) .
Altogether, the predictions made on the basis of the amino acid sequence suggested that a structurally unique kinase had been identi®ed, and emphasized the importance of studying this novel death-associated protein both at the biochemical and functional levels. 
Biochemistry of DAP-kinase
A series of biochemical studies con®rmed the structural predictions described above. The ability of the protein to phosphorylate itself and an exogenous substrate was shown by in vitro kinase assays. We proved that the recombinant protein was capable of directly binding calmodulin, and that the intrinsic kinase activity was stimulated by Ca 2+ /calmodulin . The removal of the calmodulin regulatory domain (DCaM mutant) generated a constitutively active kinase (i.e., a gain of function mutation). This is consistent with previous information on other well studied calmodulin-dependent kinases, in which the calmodulin-regulatory domain has inhibitory eects on the kinase activity, relieved by binding to Ca 2+ / calmodulin (Shoemaker et al., 1990) . DAP-kinase activity was abolished by the substitution of a conserved lysine by alanine residue within the kinase domain (K42A), thus generating an inactive kinase mutant with potential dominant-negative activity . Altogether, the complex structure of DAP-kinase that carries multiple functional domains and motifs, places it at an important functional junction within the branched network that leads to cell death, where it may receive and release a variety of input and output signals.
The cellular function of DAP-kinase
The structural studies of DAP-kinase were then complemented by functional assays. We found that overexpression of wild type DAP-kinase reduced the number of viable clones in HeLa cells . Detailed examination of the cells, early after the transfection (24 ± 48 h), indicated that overexpression of DAP-kinase killed the cells. The constitutively active DCaM mutant had stronger death-inducing eects in these overexpression assays. In contrast, the catalytically inactive kinase (K42A) completely lost its death inducing activity, and instead, its introduction slightly increased the number and the size of stable clones. The induction of cell death therefore strictly depended on the status of the intrinsic kinase activity, and the catalytic activity of this protein was clearly required for the death-promoting function of this protein. These overexpression experiments provided a second independent functional support for DAP-kinase being a death gene, in addition to the anti-sense-RNAmediated protection.
The above-mentioned observations concerning the subtle stimulatory eects that K42A DAP-kinase mutant exerted on the growth of transfected HeLa clones, promoted us to test more directly whether this catalytically inactive form of the kinase could function in a trans-dominant negative manner. We found that transfections with the catalytically inactive K42A mutant protected cells from the IFN-g-induced cell death . These studies closed a circle which started by the rescue of a death-protective antisense cDNA fragment, which interfered with protein expression, and ended by ®nding that a mutant form of the full-length DAP-kinase exerted similar eects, probably by interfering with the function of the endogenous protein.
Additional sets of experiments further strengthened the notion that DAP-kinase is a central cell death gene participating in several apoptotic systems. DAP-kinase gene was found to be widely expressed in many cells and tissues. In addition, it was found that DAP-kinase is involved in cell death induced by other cytokines, such as TNF-a, as well as death induced by detachment from extracellular matrix (Inbal et al., 1997) . Since the early signaling cascades generated by p55 TNF receptor, or detachment from extracellular matrix do not share any known common elements with IFN-g early signaling, DAP-kinase is likely to lie further downstream, and may function as a universal target at which dierent apoptotic signals eventually converge. This is consistent with the original design of the TKO approach, which was aimed at targeting genes that function downstream to the receptorgenerated early signaling. The latter was achieved by introducing IFN-responsive DNA sequences in the expression cassette driving the cDNA library, a step which made the selection dependent on intact IFN early signaling, and thus increased the probability of isolating downstream components of the pathway (Deiss and Kimchi, 1991) .
Another important issue relates to the mode of DAP-kinase regulation during programmed cell death. It was found that DAP-kinase mRNA levels were moderately increased in response to IFN-g in HeLa cells . Yet, we suspect that this may not be the major regulatory step. DAP-kinase protein may be regulated at the post-translational level, and the issue of DAP-kinase activation by a variety of apoptotic signals is currently under an extensive study.
Intracellular localization of DAP-kinase
Immunostaining indicated that DAP-kinase is localized to the cytoskeleton in association with the micro®lament system. This was further supported by biochemical fractionations, which indicated that DAP-kinase remained insoluble upon mild detergent extractions, and by application of cytoskeletal disrupting drugs. Treatment of cells with nocodazole, which disrupts the microtubule system, did not aect the solubility of DAP-kinase. Conversely, latrunculin A, a drug which disrupts the actinmicro®lament system, released a signi®cant portion of DAP-kinase molecules into the detergent-soluble fraction . Deletion analysis of DAP-kinase mapped the region mediating cytoskeleton binding to a stretch of 200 amino acids localized downstream to the ®rst P-loop motif (Figure 2 ). Most interestingly, cell killing by overexpression of DAPkinase depended on its correct localization to the cytoskeleton. A mutant of DAP-kinase which was mislocalized to the nucleus did not impose the typical changes in the actin-micro®lament organization and cell death. This was an important ®nding since loss of stress ®bres and disruption of micro®lament organization occur at early stages of epithelial and ®broblastic cell death in response to dierent apoptotic stimuli. The speci®c intracellular localization of the kinase may therefore provide a mechanistic clue as to how external signals impose these cytoskeletal changes (Cohen et al., 1997) .
Implications of DAP-kinase in tumorigenesis
Positive mediators of cell death may be lost or inactivated in tumors and therefore may function as tumor suppressor genes, as clearly documented in the case of p53. Chromosomal localization studies mapped DAP-kinase to human chromosome 9 band q34.1 (Feinstein et al., 1995b ) ± a region prone to translocations in human leukemias ± and to LOH in bladder carcinomas. In an attempt to elucidate a role for DAPkinase in oncogenesis, we ®rst tested the expression of DAP-kinase in human cell lines derived from dierent neoplasms. DAP-kinase mRNA and protein expression levels were below detection limits in 70% of B-cell lymphoma and leukemia cell lines and in 30% of cell lines derived from bladder carcinomas, breast carcinomas, and renal cell carcinomas . This stood in sharp contrast to the ®nding that DAPkinase mRNA was widely expressed in all the tested human and murine tissues, as well as in many immortalized cell lines established from normal cells.
In two bladder carcinoma and in one of the B cell lymphoma cell lines, DAP-kinase expression could be restored by treatment of cells with 5-aza-2'-deoxycytidine, a drug which inhibits DNA methylation . This suggested that loss of expression in these particular cases was due to DNA methylation, as previously reported for other tumor suppressor genes, such as p16, VHL and pRB (reviewed by Laird, 1997 ). Yet, we found, from the tumor cell lines screen, that demethylation is not an exclusive mechanism for suppressing DAP-kinase expression, in accordance with the well established paradigm that tumor suppressor genes may be lost or inactivated by multiple genetic or epigenetic alterations. These experiments provided the ®rst hint that DAP-kinase inactivation may possibly be a causative factor in the formation of tumors, as was further tested in experimental animal model systems. Obviously, a major goal in our laboratory is to enter into a large-scale screen of normally occurring human cancers, to determine the frequency of genetic and epigenetic changes of DAPkinase at dierent stages of tumor growth.
In parallel, we have carried out a second functional approach that directly tested in animal models, whether the DAP-kinase gene has tumor suppressor activity. In these experiments, we restored normal expression levels of DAP-kinase into tumor cells that have lost it, and assayed the impact of this genetic manipulation on the tumorigenic properties of these cells. This approach became even more attractive once we found that highmetastatic lung carcinoma clones, originating from two independent murine lung tumors, lacked DAP-kinase expression, in contrast to their low-metastatic counterparts which expressed normal levels (Inbal et al., 1997) . FLAG-tagged wild-type DAP-kinase was introduced into the high-metastatic Lewis carcinoma cells. Stable transfected clones in which DAP-kinase expression was restored to physiological levels displayed a normal pattern of anchorage-dependent cell growth in vitro. These transfectants were therefore assayed for their tumorigenic and metastatic activity in syngeneic mice. Strikingly, restoration of physiological levels of DAPkinase into the high-metastatic Lewis carcinoma cells suppressed their ability to form lung metastases after intravenous injections into mice. The in vitro eects were proportional to the levels of the ectopically expressed DAP-kinase, and even the low-expressors, containing levels which were below the normal levels, displayed reduced metastatic activity. The transgene also delayed local tumor growth in a foreign micro environment, yet this feature was less sensitive to DAP-kinase ectopic expression than the metastatic activity (Inbal et al., 1997) .
By selecting in vivo rare lung metastases, after injections of the original low-metastatic cells into irradiated syngeneic mice, we found that the development of these metastatic lesions correlated with loss of the endogenous DAP-kinase expression. Moreover, treatment of cells recovered from one of these DAPkinase negative lung lesions with 5-aza-2'-deoxycytidine, restored protein expression to the normal levels. DNA methylation was therefore also responsible for silencing the endogenous DAP-kinase gene in some of the in vivo selected lung lesions (Inbal et al., 1997) . Altogether, these experiments suggested that loss of DAP-kinase expression provides a positive selective advantage during the formation of lung metastases.
Next, the mechanisms underlying the suppressive eects of DAP-kinase on metastasis and local tumor growth were studied. In situ TUNEL staining was performed on histological sections of local tumors. It was found that the apoptotic index in the slow growing local tumors, formed by the DAP-kinase-transfected cells, was higher than the value measured in the tumor mass formed by the control clone (Figure 3 ). These To directly address this issue, the transfected cells were exposed in vitro to two types of apoptotic stimuli of the sort encountered by metastasizing cells at the dierent stages of malignancy, such as TNF-a and anchorageindependent cell growth. The transfectants displayed higher sensitivity to the apoptotic eects of TNF-a: fragmented nuclei appeared much faster, and total cell death was greater. A second type of an apoptotic stress was induced by growing cells under anchorageindependent conditions in soft agar. In contrast to the parental high-metastatic clone which formed large viable colonies in semi-solid medium, the various DAPkinase transfected clones formed small colonies comprising of apoptotic cells. Based on these experiments it is suggested that the DAP-kinase-mediated suppression of metastasis results, at least in part from increased sensitivity to various death-inducing stimuli. It is proposed that loss of DAP-kinase expression provides a novel mechanism that links suppression of apoptosis to metastasis (Inbal et al., 1997) .
DAP-3 studies
The DAP-3 gene, localized to chromosome 1 band q21 , codes for a protein of 46 kDa which carries a potential`P-loop' motif, suggesting that it is a nucleotide binding protein. The gene is transcribed into a single 1.7 kb mRNA, which is ubiquitously expressed in dierent cells and tissues (Kissil et al., 1995) . The notion that DAP-3 functions as a major positive mediator of cell death was supported by two independent lines of evidence. One of them is based on the original assay ± which in fact led to the identi®cation of this gene, i.e., protection from cell death conferred by reduced expression of the protein. The assay in this experiment was based on neutral dye uptake into viable cells. It showed that transfection with a vector expressing anti-sense DAP-3 RNA caused a signi®cant increase in the fraction of cells that remained viable in the continuous presence of IFN-g. Western blot analysis, performed by using anti-DAP-3 polyclonal antibodies, con®rmed that the antisense RNA expression indeed reduced the steady state levels of DAP-3 protein in the continuous presence of IFN-g (Kissil et al., 1995) . The second line of evidence came from overexpression of the full-length sense cDNA. Conceptually, it is well accepted now that overexpression of a single gene that is part of a molecular pathway that leads to cell death, is often itself sucient to trigger the entire cell death process, even in cases where the normal regulation of the gene during apoptosis does not involve elevation of expression. We found in this respect that ectopic expression of DAP-3 from a constitutive promoter induced the death of HeLa cells within 48 ± 72 h, leading to a signi®cant reduction in the number of drug resistant stable clones after 2 weeks (Kissil et al., 1995) . Thus, the ®nding that overexpression of DAP-3 induced cell death provides an independent support for this gene, being a positive mediator of cell death. The DAP-3-induced cell death was considerably weakened by introducing a single amino acid mutation within the P-loop motif. This indicates that the nucleotide-binding property is critical for the death promoting functions of the protein (Kissil et al., 1999) .
DAP-5 studies
DAP-5 gene codes for a 97 kDa protein, that is highly homologous to translation initiation factor 4G (eIF4GI; p220), with an overall 27% identity and 48% similarity between the two at the amino acid level (Levy-Strumpf et al., 1997) . eIF4GI functions as a scaold for assembling several initiation factors that direct ribosomes to RNA at the cap site. The Nterminal part of eIF4GI binds eIF4E, the well known cap-binding protein, whereas the middle region of the protein binds eIF3 and eIF4A translation initiation factors. The cap binding end of eIF4GI is cleaved during lytic infection with some RNA viruses by a cellular protease. By this mechanism the virus inhibits the cellular cap dependent translation and recruits the translation machinery exclusively towards the uncapped viral RNA. Strikingly, the DAP-5 protein lacks the N-terminal region that is necessary for capdependent translation while it shares high homology at the core region which binds to eIF3 and eIF4A. The Cterminus part of the protein shares less homology to eIF4GI. Thus, DAP-5 may represent a naturally occurring form of the cleaved eIF4GI, linking translational control to the process of cell death (Levy-Strumpf et al., 1997) .
Interestingly, the DAP-5 cDNA fragment which was rescued by the TKO selection was a sense fragment. It coded for a mini-protein that encompassed the less conserved C-terminal part of the protein (see the scheme in Figure 4) . The domain structure of DAP-5 predicts that this selected death-protecting mini protein, depleted of its eIF3 and eIF4A-binding sites, should function in a dominant-negative manner; the reduced homology to eIF4GI within this protein fragment predicts that it might compete speci®cally with the full-length DAP-5 (Levy-Strumpf et al., 1997). The two yeast eIF4G homologs lack the C-terminal region of the protein, suggesting that this region was acquired later in evolution and possibly carries a regulatory function. This regulatory region is targeted by the sense cDNA fragment that was isolated.
What is the biochemical function of DAP-5? One angle in this issue was studied by the group of N Sonenberg who independently isolated this gene and named it p97. This group has shown that DAP-5/p97 protein binds to eIF3 and eIF4A, and that like the cleaved eIF4GI, it fails to bind the cap-binding protein eIF4E . Assays based on transient transfections showed that DAP-5/p97 overexpression repressed both cap-dependent translation as well as cap-independent translation from EMCV internal ribosomal entry sites (IRES). In contrast, eIF4G supported both translation pathways. Based on these transfection studies, they suggested that DAP-5/p97 may function as a repressor of translation that titrates out eIF3 and eIF4A from cells. Later reported that unlike eIF4GI which possesses two independent eIF4A-binding sites (one at the central core, and the other in the C-terminus), DAP-5 possesses a single binding site. According to their interpretation, the lack of the second binding site could prevent a possible function of DAP-5/p97 as a cap-independent translational factor, thus supporting the repressor hypothesis mentioned above. However another recently cloned protein belonging to the eIF4G family, PAIP, enhanced translation in the absence of the second C-terminal eIF4A-binding site (Craig et al., 1998) . Another ®nding which is not compatible with the simple repressor hypothesis, is the constitutive and abundant expression of DAP-5/p97 in normally growing cells. This raised an alternative working model which proposed that during apoptosis or other stress conditions, DAP-5/p97 may be modi®ed, by speci®c transcription/translation regulatory processes, into novel forms which ful®ll the death-promoting functions of this gene. Indeed, in a recent series of experiments we found that during cell death, initiated by Fas receptors or by p53 activation, p97/DAP-5 was rapidly converted into a novel truncated form, lacking the C-terminus. It is possible that this novel form of the protein may drive cap-independent translation of certain critical cellular mRNAs required for each cell death, an open issue which awaits further investigation.
Another line of research recently ended up, quite surprisingly, in the independent cloning of DAP-5 gene. In this work Yamanaka et al. (1997) , developed an elegant strategy to clone novel targets for the RNA editing enzyme, apobec-1. Apobec-1 is the catalytic subunit of the editosome multi-protein complex which substitutes cytidine to uridine by deaminase activity. The strategy was based on a modi®ed dierential display technique to selectively amplify mRNAs that were edited in the livers of transgenic mice overexpressing apobec-1. By doing so, they identi®ed a novel target which they called NAT1 (for novel apobec-1 target no. 1). NAT1 mRNA was extensively edited at multiple sites in these livers, creating many stop codons. It should be mentioned that although this arti®cial system of hyperediting fails to provide the precise physiological editing sites along the RNA molecule, it de®nitively scores the real potential targets for the apobec-1 activity. Surprisingly, NAT1 was identi®ed as the mouse homolog of the human DAP-5 gene (Yamanaka et al., 1997) . This work opens up the possibility that apobec-1-mediated DAP-5 RNA editing might be one of a few mechanisms which regulate DAP-5 function by generating novel forms of the protein.
DAP-1 studies
DAP-1 is a 15 kDa, proline rich, basic protein. It has two potential cdk phosphorylation sites; the phosphorylated DAP-1 protein displayed a dierent pattern of mobility on gels . Immunostaining and biochemical fractionation established that this protein is localized in the cytoplasm. Yet, no clues were so far provided concerning the biochemical function of this protein. At the cellular level, the death-promoting eects of the protein were prominent, and overexpression of the full-length protein potentiated the killing eects of IFN-g (T Raveh and A Kimchi, unpublished results).
The cathepsin D protease connection to apoptosis
One of the surprises in the TKO selection was the identi®cation of the insert carried by plasmid #229 as an anti-sense cDNA fragment directed against human cathepsin D aspartic protease (Table 1) . Obviously, proteases were expected to be isolated during the selection, yet our prediction was that they will fall into the known family of caspases. The lysosomal cathepsin D has a wide range of activities in mammalian cells, mostly executed in the lysosomal compartment during steady state growth conditions. It was only after a detailed study of the fate of this protease during cell death, that an interesting unexpected scenario has emerged, consistent with an active role in apoptosis (Deiss et al., 1996) .
The initial analysis of the secondary stable clones indicated that the high levels of cathepsin D anti-sense RNA protected the HeLa cells from IFN-g and Fas/ APO-1-induced death. Since pepstatin A, a peptide inhibitor of aspartic proteases, was extensively used in the past to speci®cally suppress cathepsin D activity in intact cells, we used it in our systems. It was found that this peptide inhibitor suppressed cell death in HeLa cells exposed to IFN-g and to the anti-Fas/APO-1 agonistic antibodies. Protection by pepstatin A was also detected during the TNF-a-induced programmed cell death of U937 cells (Deiss et al., 1996) . We thus established the role of this protease in three dierent apoptotic systems.
The next challenge was to understand how a housekeeping lysosomal protease is recruited to the tightly regulated process of programmed cell death. We found that this gene has an interesting pattern of regulation during cell death. The mRNA expression of cathepsin D was elevated and the processing of the protein was regulated in the dying cells. As a consequence, high steady-state levels of an intermediate, proteolytically-active, single chain form of this protease accumulated in cells (Deiss et al., 1996) . This form is present at low steady-state levels in normally growing cells, and is usually found in pre-lysosomal compartments. Its abnormal accumulation in apoptotic cells further suggested that changes in cathepsin D intracellular localization, and hence in the spectrum of potential substrates might occur during cell death.
Recently, El-Deiry and co-workers reported that cathepsin D has a role in p53-dependent apoptosis. Using subtractive hybridization screening, they isolated cathepsin D as an upregulated transcript appearing in cells undergoing adriamycin-induced apoptosis, in a p53-dependent manner (Wu et al., 1998) . They found that cathepsin D mRNA levels increased in wild-type p53-expressing cell lines following adriamycin addition. Other DNA damaging reagents were similarly eective in elevating cathepsin D expression. Two p53 DNAbinding sites were identi®ed in the cathepsin D promoter. They bound to p53 in vitro, and appeared to mediate transactivation by p53 of a reporter gene driven by the cathepsin D promoter. It appears from this work that cathepsin D also mediates apoptotic signals that involve DNA damage and are p53-dependent, thus further extending the spectrum of apoptotic signals that use this aspartic protease to intracellular signals as well.
Altogether, cathepsin D may be added to the growing list of proteases that function as positive mediators of apoptosis. How its function is related to the cascade of caspase activation during apoptosis is an issue to be studied.
Conclusions and prospects for the future
While the research on the novel DAP genes is still very far from completion, a few common interesting paradigms already emerge. The start points in the isolation of these genes were the selected short cDNA fragments, which in most cases directed the transcription of high levels of anti-sense RNAs. In the case of DAP-5, a mini protein was translated from the functional sense cDNA fragment. This means that the selection worked by either reducing the levels or suppressing the function/activation of the corresponding proteins. Later on, once the full-length proteins were further characterized, we designed speci®c mutations within the DAP genes, or used small peptide inhibitors, to illustrate by a few other independent approaches the rate limiting functions that these genes display in apoptosis. Two classical examples discussed in this paper are the K42A dominant negative mutant of DAPkinase, and the pepstatin A peptide inhibitor, which suppressed the function of DAP-kinase and of cathepsin D proteins, respectively. These reagents displayed cell death protective eects similar in their nature to the eects of the original anti-sense cDNAs, thus con®rming by a few independent molecular tools that these proteins are indispensable in some of the apoptotic associated events.
It should be emphasized that genes identi®ed by virtue of their rate limiting function in apoptosis, as performed in these studies, could either interact indirectly with the main death pathways, or be central components of the main death pathways themselves. A few criteria should distinguish between the two possibilities; the detailed study of these criteria indicate very clearly that some of the DAP genes are integral components of death pathways.
One of the most important criterion relates to the issue of regulation. If the studies indicate that a gene, which was initially rescued through its function, is actually tightly regulated by the apoptotic trigger, the probability increases that an intrinsic component of the apoptotic pathway has been selected. The regulation may take place at multiple dierent levels, including transcriptional, post-transcriptional, translational and post-translational. One of the examples discussed in this paper, is the cathepsin D. Following its rescue as a gene whose function is rate limiting during apoptosis, it was found that the gene is tightly regulated at a few independent levels. First, it was found that dierent killing cytokines elevated the cathepsin D mRNA expression. Second, a speci®c alteration in the processing of this protein occurred during apoptosis, resulting in the accumulation of an active prelysosomal single chain precursor. And third, p53 binding sites were identi®ed in the promoter region, elevating the transcription of the gene in response to DNA damage. Also, the regulation of DAP-kinase and of DAP-5 by the dierent apoptotic triggers, is under extensive study in our laboratory, as detailed above.
The second criterion refers to the range of apoptotic triggers which depend on the rescued gene. If DAP gene's function is not restricted to a single external apoptotic stimulus, then a more general role in death pathway(s) may be attributed to the gene. For example: DAP-kinase, and cathepsin D mediate Fas and TNF-a-induced cell death in addition to mediating the IFN-g eects. Moreover, DAP-kinase also mediates cell death induced by detachment from extracellular matrix (named anoikis). Altogether, the spectrum of apoptotic stimuli that converge into DAP-genes seems to be very wide, suggesting that they serve as common downstream mediators to various signals.
DAP-kinase, DAP-3, DAP-1, and DAP-5 were highly conserved in evolution. Recently we have isolated the C. elegans homolog of DAP-3, which displays 35% identity at the amino acid level (Kissil et al., 1999) . Moreover, each of these genes represents the prototype of a novel gene family. In this respect, two novel DAP-kinase homologs which share 80% identity in their catalytic domains, were recently identi®ed. No homology was found outside of the catalytic domain. One of the homologs, named ZIP-kinase, contains leucine zipper structure at its C terminus and was localized to the nuclei of cells (Kawal et al., 1998) . It displays apoptotic functions which like in the case of DAP-kinase depend on its intrinsic kinase activity. Its rat counterpart was also independently cloned and characterized by Kogel et al. (1998) . DAP-5 belongs to the extended eIF4G family consisting of the aforementioned eIFGI, and the recently cloned eIF4GII (Gradi et al., 1998) , and PAIP (Craig et al., 1998) . A family of DAP-1 related proteins was recently identi®ed by the EST data bank searches.
The ubiquitous expression of these genes in many cell types and tissues, and the high degree of conservation among dierent organisms imply that we managed to isolate evolutionary conserved and important components of cell death pathways that are common to various cells.
Finally, the link to cancer and to other pathologies is another important criterion in evaluating the physiological and pivotal role of DAP genes. The best indications that we have so far relate to the DAPkinase gene which possesses strong anti-metastatic activities. This aspect in the function of the gene was attributed at least partially, to the high susceptibility that it conferred to apoptotic stimuli, some of which operate during metastasis. For instance, upon entering into circulation, the invading metastasizing cells may be killed by interactions with monocytes, natural killer cells, and neutrophils, by exposure to cytokines, to nitric oxide anions, or by dierent mechanical stresses. The loss of DAP-kinase conveys to the metastasizing cells strong positive selection to resist the apoptotic stress, as also shown by the in vivo selections of lung metastases in mice model systems. Frequent inactivating mutations in human tumors, if detected, should provide an additional independent support that DAP genes display a major function in keeping cells under the tight control of apoptotic mechanisms that take place normally in vivo. Obviously, other mechanisms may contribute to the tumor suppressive functions of DAP genes, in addition to mediating apoptotic responses.
Intriguingly, the genes which were rescued code for proteins that have a diverse spectrum of biochemical activities, suggesting that we managed to hit multiple elements along cell death pathway(s). These activities include a structurally unique calcium/calmodulindependent kinase (DAP-kinase), a nucleotide binding protein (DAP-3), an aspartyl lysosomal protease (cathepsin D), a novel translation initiation factor (DAP-5), and a small proline-rich cytoplasmic protein (DAP-1). The major challenge now is to analyse how these diverse activities constitute biochemical pathway(s) leading to programmed cell death. This depends on studying the nature of interactions between the individual DAP genes on the one hand, and determining their functional position with respect to the other well known positive and negative mediators of apoptosis, on the other hand. For instance, the functional interaction between the dierent DAP genes can be worked out by trying to rescue the deathpromoting eects of one DAP gene by the dominant negative mutant of another DAP gene, or by studying combinatorial death-promoting eects by double and triple transfections. The possible functional interactions with members of the bcl-2 family, or with the caspases, can be assessed now in a similar manner, by stable or transient transfections, or by the use of speci®c peptide inhibitors. Caspase could function in parallel to the biochemical pathways which involve DAP genes, or alternatively may be integrated into these pathways either as upstream modulators, and/or downstream executors.
